Chemours Ebit Per Revenue from 2010 to 2024

CC Stock  USD 21.53  0.73  3.51%   
Chemours' Ebit Per Revenue is decreasing over the years with slightly volatile fluctuation. Overall, Ebit Per Revenue is projected to go to -0.01 this year. During the period from 2010 to 2024 Chemours Ebit Per Revenue annual values regression line had geometric mean of  0.08 and mean square error of  0. View All Fundamentals
 
Ebit Per Revenue  
First Reported
2010-12-31
Previous Quarter
(0.02)
Current Value
(0.01)
Quarterly Volatility
0.0821329
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Chemours financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Chemours' main balance sheet or income statement drivers, such as Depreciation And Amortization of 313.9 M, Interest Expense of 146.3 M or Selling General Administrative of 797.3 M, as well as many indicators such as Price To Sales Ratio of 0.55, Dividend Yield of 0.0409 or PTB Ratio of 8.43. Chemours financial statements analysis is a perfect complement when working with Chemours Valuation or Volatility modules.
  
Check out the analysis of Chemours Correlation against competitors.

Latest Chemours' Ebit Per Revenue Growth Pattern

Below is the plot of the Ebit Per Revenue of Chemours Co over the last few years. It is Chemours' Ebit Per Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Chemours' overall financial position and show how it may be relating to other accounts over time.
Ebit Per Revenue10 Years Trend
Slightly volatile
   Ebit Per Revenue   
       Timeline  

Chemours Ebit Per Revenue Regression Statistics

Arithmetic Mean0.11
Geometric Mean0.08
Coefficient Of Variation77.64
Mean Deviation0.07
Median0.10
Standard Deviation0.08
Sample Variance0.01
Range0.2324
R-Value(0.56)
Mean Square Error0
R-Squared0.31
Significance0.03
Slope(0.01)
Total Sum of Squares0.09

Chemours Ebit Per Revenue History

2024 -0.0145
2023 -0.0153
2022 0.13
2021 0.14
2020 0.1
2019 0.0309
2018 0.19

About Chemours Financial Statements

Chemours stakeholders use historical fundamental indicators, such as Chemours' Ebit Per Revenue, to determine how well the company is positioned to perform in the future. Although Chemours investors may analyze each financial statement separately, they are all interrelated. For example, changes in Chemours' assets and liabilities are reflected in the revenues and expenses on Chemours' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Chemours Co. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Ebit Per Revenue(0.02)(0.01)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out the analysis of Chemours Correlation against competitors.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.65)
Dividend Share
1
Earnings Share
0.5
Revenue Per Share
38.519
Quarterly Revenue Growth
0.009
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.